Search research articles
Contact Us
Filters
Showing results (91-100 of 173) with videos related to
Page
of 18
Sort By:
Molecular Imaging and Biology
|
June 20, 2014
Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters
Hiroyuki Okudaira, Shuntaro Oka, Masahiro Ono, et al.
Academic Radiology
|
March 14, 2015
The nuclear medicine therapy care coordination service: a model for radiologist-driven patient-centered care
Valeria M Moncayo, Kimberly E Applegate, Richard Duszak, et al.
Clinical Nuclear Medicine
|
December 27, 2019
Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center
Mohammad Elsayed, Robert M Ermentrout, Ila Sethi, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2017
Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study
Ayse Tuba Kendi, David Brandon, Jeffrey Switchenko, et al.
Proceedings of Spie--The International Society for Optical Engineering
|
September 24, 2016
Random Walk Based Segmentation for the Prostate on 3D Transrectal Ultrasound Images
Ling Ma, Rongrong Guo, Zhiqiang Tian, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
November 26, 2013
Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma
Bree R Eaton, Hyun S Kim, Eduard Schreibmann, et al.
Molecular Imaging and Biology
|
May 6, 2008
Investigation of emission-transmission misalignment artifacts on rubidium-82 cardiac PET with adenosine pharmacologic stress
David M Schuster, Raghuveer K Halkar, Fabio P Esteves, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2007
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma
David M Schuster, John R Votaw, Peter T Nieh, et al.
Clinical Nuclear Medicine
|
June 11, 2024
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study
Nima Kokabi, Linzi A Webster, Howard Dabbous, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2022
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (<sup>18</sup>F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 173) with videos related to
Sort By:
Page
of 18
Molecular Imaging and Biology
|
June 20, 2014
Accumulation of trans-1-amino-3-[(18)F]fluorocyclobutanecarboxylic acid in prostate cancer due to androgen-induced expression of amino acid transporters
Hiroyuki Okudaira, Shuntaro Oka, Masahiro Ono, et al.
Academic Radiology
|
March 14, 2015
The nuclear medicine therapy care coordination service: a model for radiologist-driven patient-centered care
Valeria M Moncayo, Kimberly E Applegate, Richard Duszak, et al.
Clinical Nuclear Medicine
|
December 27, 2019
Incidence of Radioembolization-Induced Liver Disease and Liver Toxicity Following Repeat 90Y-Radioembolization: Outcomes at a Large Tertiary Care Center
Mohammad Elsayed, Robert M Ermentrout, Ila Sethi, et al.
American Journal of Nuclear Medicine and Molecular Imaging
|
September 16, 2017
Head and neck PET/CT therapy response interpretation criteria (Hopkins criteria) - external validation study
Ayse Tuba Kendi, David Brandon, Jeffrey Switchenko, et al.
Proceedings of Spie--The International Society for Optical Engineering
|
September 24, 2016
Random Walk Based Segmentation for the Prostate on 3D Transrectal Ultrasound Images
Ling Ma, Rongrong Guo, Zhiqiang Tian, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
November 26, 2013
Quantitative dosimetry for yttrium-90 radionuclide therapy: tumor dose predicts fluorodeoxyglucose positron emission tomography response in hepatic metastatic melanoma
Bree R Eaton, Hyun S Kim, Eduard Schreibmann, et al.
Molecular Imaging and Biology
|
May 6, 2008
Investigation of emission-transmission misalignment artifacts on rubidium-82 cardiac PET with adenosine pharmacologic stress
David M Schuster, Raghuveer K Halkar, Fabio P Esteves, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 6, 2007
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma
David M Schuster, John R Votaw, Peter T Nieh, et al.
Clinical Nuclear Medicine
|
June 11, 2024
Resin-Based 90 Y Tumor Dose as a Predictor of Duration of Response and Survival in Patients With Surgically Unresectable Hepatocellular Carcinoma : A Prospective Single-Arm Study
Nima Kokabi, Linzi A Webster, Howard Dabbous, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 13, 2022
Randomized Trial of Conventional Versus Conventional Plus Fluciclovine (<sup>18</sup>F) Positron Emission Tomography/Computed Tomography-Guided Postprostatectomy Radiation Therapy for Prostate Cancer: Volumetric and Patient-Reported Analyses of Toxic Effects
Vishal R Dhere, David M Schuster, Subir Goyal, et al.
Page
of 18